| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,157 | 47,496 | 43,875 | 155,661 | | Cost of Revenue | 15,092 | 12,666 | 11,475 | 5,536 | | | Gross Profit | 33,065 | 34,830 | 32,400 | 150,125 | | | Operating Expenses | | Research Development | 20,664 | 25,586 | 24,838 | 22,669 | | Selling General and Administrative | 20,625 | 19,268 | 20,835 | 14,568 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,224) | (10,024) | (13,273) | 112,888 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,021 | 1,498 | 2,399 | 1,933 | | Earnings Before Interest And Taxes | (7,203) | (8,526) | (10,874) | 114,821 | | Interest Expense | 1,566 | 1,709 | 2,851 | 2,436 | | Income Before Tax | (8,769) | (10,235) | (13,725) | 112,385 | | Income Tax Expense | (60) | (70) | (130) | (330) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,709) | (10,165) | (13,595) | 112,715 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,709) | (10,165) | (13,595) | 112,715 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,709) | ($10,165) | ($13,595) | $112,715 |
|
0.51% Nasdaq 
Income Statement
